<DOC>
	<DOCNO>NCT02407717</DOCNO>
	<brief_summary>Patients cancer hospitalize acute medical illness increase risk venous thromboembolic event . Although international guideline suggest use thromboprophylaxis patient , recommendation base study include percentage patient cancer without primarily focus high risk group . Since patient cancer present increase risk bleeding complication critical evaluate safety thromboprophylaxis cancer group . Recent study suggest limit use thromboprophylaxis patient . The aim study evaluate use , efficacy safety thromboprophylaxis medical cancer patient hospitalize acute medical disease . Design : observational , prospective study Primary end-point : incidence major clinically relevant non major bleed hospitalization Secondary endpoint : frequency use , dose contraindication pharmacological thromboprophylaxis ; venous thromboembolic event three month discharge</brief_summary>
	<brief_title>Venous Thromboembolism Bleeding Hospitalized Medical Patients With Cancer</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>patient cancer hospitalize acute medical illness current use oral parenteral anticoagulant treatment inform consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>